By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DBV Technologies 

29 rue du Faubourg

Saint Jacques  Paris  75014  France
Phone: 33-0-1-55-389270 Fax: 33-0-1-41-312882


Company News
DBV Tech Initiates Phase III Study Of Viaskin Peanut In Peanut-Allergic Patients One To Three Years Of Age 8/2/2017 9:39:36 AM
Half-Year Report On The DBV Tech Liquidity Contract With Natixis 7/6/2017 12:54:17 PM
DBV Tech Announces Appointment Of Julie O'Neill To Board Of Directors 6/16/2017 10:53:56 AM
DBV Tech Announces Results Of Its 2017 Ordinary And Extraordinary General Meeting 6/16/2017 10:52:46 AM
DBV Tech To Attend Upcoming Investor Conferences 6/2/2017 1:19:15 PM
DBV Tech Highlights Research Presentation Of EPIT For The Treatment Of Crohn's Disease At Digestive Disease Week 2017 5/8/2017 10:36:04 AM
DBV Tech Reports March 31, 2017 Cash Position 4/28/2017 9:50:22 AM
DBV Tech To Attend The 10th Kempen Life Sciences Conference 4/5/2017 11:28:23 AM
DBV Tech, BioNet-Asia And Geneva University Hospitals Announce Phase I Trial Results Of Viaskin rPT In Pertussis Booster Vaccination 3/31/2017 8:51:06 AM
DBV Tech Announces Filing Of Its 2016 "Document De Référence" And Annual Report On Form 20-F 3/23/2017 10:19:14 AM